ImmunoGen, Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

1980

Location

Waltham MA US

Primary Industry

Biotechnology

Established

1980

Firm Ownership

Investment Team Staff

Total Staff

Request a demo to show more

Timeline of Key Events

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin

30 Jun 2013

35,535,000

(73,009,000)

(205.5%)

(68,368,000)

(192.4%)

(72,811,000)

(204.9%)

30 Jun 2014

59,896,000

68.6%

(71,531,000)

(119.4%)

(66,933,000)

(111.7%)

(71,364,000)

(119.1%)

30 Jun 2015

85,541,000

42.8%

(54,455,000)

(63.7%)

(48,942,000)

(57.2%)

(60,739,000)

(71%)

30 Jun 2016

60,002,000

(29.9%)

(124,991,000)

(208.3%)

(119,664,000)

(199.4%)

(144,817,000)

(241.4%)

31 Dec 2017

115,447,000

(58,982,000)

(51.1%)

(53,019,000)

(45.9%)

(96,012,000)

(83.2%)

31 Dec 2018

53,446,000

(161,449,000)

(302.1%)

(154,038,000)

(288.2%)

(168,843,000)

(315.9%)

31 Dec 2019

82,271,000

53.9%

(92,173,000)

(112%)

(88,145,000)

(107.1%)

(104,133,000)

(126.6%)

31 Dec 2020

31 Dec 2021

31 Dec 2022

Unlock the recent years of financials and more for ImmunoGen, Inc..

Request a demo to see more.

Employee Data

Want to see the Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.